@article{gandemer:hal-01064611,
TITLE = {Clinical value of pre-transplant minimal residual disease in childhood lymphoblastic leukaemia: the results of the French minimal residual disease-guided protocol},
AUTHOR = {Gandemer, Virginie and Pochon, C{\'e}cile and Oger, Emmanuel and Dalle, Jean-Hugues H. and Michel, G{\'e}rard and Schmitt, Claudine and Berranger, Eva De and Galambrun, Claire and Cav{\'e},
H{\'e}l{\`e}ne and Cayuela, Jean-Michel and Grardel, Nathalie and Macintyre, Elizabeth and Margueritte, Genevi{\`e}ve and M{\'e}chinaud, Fran{\c c}oise and Rorhlich, Pierre and Lutz, Patrick and Demeocq, Fran{\c c}ois and Schneider, Pascale and Plantaz, Dominique and Poir{\'e}e, Marilyne and Bordigoni, Pierre},
URL = {https://hal.science/hal-01064611},
JOURNAL = {British Journal of Haematology},
PUBLISHER = {Wiley},
VOLUME = {165},
NUMBER = {3},
PAGES = {392--401},
YEAR = {2014},
DOI = {10.1111/bjh.12749},
KEYWORDS = {Adjuvants ; Immunologic ; Adolescent ; Antineoplastic Combined Chemotherapy Protocols ; Child ; Preschool ; Combined Modality Therapy ; Disease-Free Survival ; Female ; Hematopoietic Stem Cell Transplantation ; Humans ; Male ; Neoplasm ; Residual ; Precursor Cell Lymphoblastic Leukemia-Lymphoma ; Prognosis ; Prospective Studies ; Remission Induction ; Treatment Outcome},
HAL_ID = {hal-01064611},
HAL_VERSION = {v1},
}